Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Apply
Obinutuzumab & CC-99282
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step